Latest healthtech and biotech deals
The largest from last week:
🇺🇸 ArsenalBio, biotech company that aims to treat solid tumors with “programmable” T cell therapies, raised $220M in Series B. It is preparing for clinical testing of its ovarian cancer drug candidate, AB-1015, and expects to dose the first patient later this year.
🇮🇳 1mg, online pharmacy platform, became unicorn after raising $40M at a $1.3B valuation. Explore this list of other online pharmacies.
🇫🇮 Varjo, developer of high-end enterprise XR headsets, raised $40M in Series D.
Varjo’s human-eye resolution mixed and virtual reality headsets take medical professionals to a higher level of focus and emotional engagement. With true-to-life XR/VR, medical personnel can prepare for the most challenging real-life scenarios.
Other notable deals from around the globe:
🇩🇪 Ottonova, digital health insurer, raised €34M in Series F. In addition to private full health insurance and supplementary health insurance, ottonova’s portfolio also includes software solutions for the insurance industry.
🇬🇧 Healthily, AI symptom checking app, raised $20M at a $150M valuation. Now it will focus on the US, where it has landed a partnership with retail giant Walmart. The partnership means Healthily will engage with patients and help them find the right kind of remedies and support on Walmart’s website.
🇬🇧 🇫🇷 Apricity, virtual fertility clinic, raised €17M in Series B to expand its virtual fertility clinic solution across Europe. The funding was led by MTIP, the Swiss healthtech investor, with participation from Iris Ventures.
Read up on all the latest health deals in Dealroom.co
%20(1).png?upscale=true&width=1200&upscale=true&name=unnamed%20(7)%20(1).png)
